Protocol Overview
Dosing Protocol
Standard
300 mcg
250 mcg
1x daily (AM fasted)
8-12 weeks
Enhanced Repair
300 mcg (AM)
250 mcg 2x (AM + PM)
2x daily BPC
Advanced
300 mcg 2x (AM + PM)
2x daily both
Key principle: AOD-9604 requires fasted administration (no food 30 min before/after). Both peptides can be drawn into the same syringe. For injury focus, inject BPC-157 near the injury site; for systemic benefits, inject in abdominal fat.
Reconstitution Guide
AOD-9604 (5mg vial)
Diluent: 2mL bacteriostatic water
Concentration: 2.5mg/mL
300mcg dose: 12 units on insulin syringe
Vial yield: ~16 doses at 300mcg
BPC-157 (5mg vial)
250mcg dose: 10 units on insulin syringe
Vial yield: 20 doses at 250mcg
Combined draw: 22 units total for both
Expected Timeline
Side Effects & Monitoring
Common Side Effects
Injection site redness (mild, transient)
Mild headache during first few days (uncommon)
Slight drowsiness with BPC-157 (some subjects)
Both peptides have excellent safety profiles. AOD-9604 does not affect blood glucose, IGF-1, or cortisol. BPC-157 is derived from gastric juice and has shown no toxicity in research.
Precautions
AOD-9604: take fasted for optimal fat loss
BPC-157: theoretical concern with active cancer (angiogenesis)
Monitor blood glucose if diabetic
Not recommended during pregnancy
Stacking Additions
Add to This Stack
CJC-1295/Ipamorelin: GH support at night for enhanced recomp
5-Amino-1MQ: NNMT inhibition for additional fat metabolism
TB-500: Enhanced tissue repair (loading phase)
L-Carnitine: Fatty acid transport support
Popular Expansions
Full Recomp: AOD/BPC + CJC/Ipa at night + fasted cardio
Injury Recovery: AOD/BPC + TB-500 2mg 2x/wk
Metabolic: AOD/BPC + 5-Amino-1MQ 100mg/day oral
Blood Work Recommendations
Metabolic
Fasting glucose, insulin, HbA1c, lipid panel
Baseline, Week 6, Week 12
Inflammation
hs-CRP, ESR
Liver Function
ALT, AST, GGT
Baseline, Week 12
Body Composition
DEXA scan, waist circumference
Related Tools & Resources
Related Resources